{"url_path":"/sec/pavm/8-k/2026-06-24/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1624326/0001493152-26-029944-index.html","accession_number":"0001493152-26-029944","cik":"0001624326","ticker":"PAVM","issuer_name":"PAVmed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1624326/0001493152-26-029944-index.html","primary_entity_key":"0001624326","primary_entity_name":"PAVmed Inc."},"word_count":466,"has_tables":true,"body_markdown":"**Item 5.07.**\n**Submission of Matters to a Vote\nof Security Holders.**\n\n** **\n\nOn\nJune 24, 2026, PAVmed Inc. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”).\nStockholders representing approximately 59.6% of the shares outstanding and entitled to vote were present in person or by proxy. At the\nAnnual Meeting, the stockholders elected each of management’s nominees for director and approved the other matters considered.\nA description of the matters considered by the stockholders and a tally of the votes on each such matter are set forth below.\n\n \n\n1.\nThe election of two members of the Company’s board of directors (the “Board”) as Class A directors, to hold\noffice until the third succeeding annual meeting and until their respective successors are duly elected and qualified. The Board is divided\ninto three classes, Class A, Class B and Class C. As of the Annual Meeting, there were two directors in Class A, Ronald M. Sparks and\nTimothy Baxter, whose terms expired at the Annual Meeting, two directors in Class B, Sundeep Agrawal, M.D. and Debra J. White, whose\nterms expire at the 2027 annual meeting of stockholders, and two directors in Class C, Lishan Aklog, M.D. and Michael J. Glennon, whose\nterms expire at the 2028 annual meeting of stockholders. The board nominated Mr. Sparks and Mr. Baxter for re-election as Class A directors.\nEach of the board’s nominees for director was elected, as follows:\n\n \n\nName \nFor  \nAuthority Withheld  \nBroker Non-Votes \n\nRonald M. Sparks \n 3,810,460  \n 67,490  \n 457,041 \n\nTimothy Baxter \n 3,815,060  \n 62,890  \n 457,041 \n\n \n\n2.\nA proposal to approve amendments to the Company’s Employee Stock Purchase Plan (the “ESPP”) to (i) increase\nthe total number of shares of the Company’s common stock available under the ESPP by an additional 200,000 shares, from 15,774\nshares to 215,774 shares and (ii) raise the annual limit for increases under the evergreen provision from 5,556 to 500,000 shares. The\namendments were approved, as follows:\n\n \n\nFor \nAgainst  \nAbstain  \nBroker Non-Votes \n\n3,780,854 \n 95,874  \n 1,222  \n 457,041 \n\n \n\nA\nmore complete description of the ESPP, as amended, is set forth beginning on page 8 under “*The ESPP Proposal*” in the\nDefinitive Proxy Statement on Schedule 14A, filed by the Company on April 30, 2026 (the “Definitive Proxy Statement”),\nwhich description is incorporated herein by reference. The description of the amendments does not purport to be complete and is qualified\nin its entirety by reference to the full text of the ESPP, which is included as Annex A to the Definitive Proxy Statement and is incorporated\nherein by reference.\n\n \n\n3.\nA proposal to ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered certified public accounting firm\nfor the year ending December 31, 2026. The ratification of the appointment of CBIZ CPAs P.C. was approved, as follows:\n\n \n\nFor \nAgainst  \nAbstain  \nBroker Non-Votes \n\n4,306,623 \n 25,814  \n 2,554  \n —"}